- Modification of mRNA constructs for controlled pharmacokinetics of protein production
- Development of non-viral vectors for gene delivery
- Application of emerging RNA therapeutics to regenerative medicine
Skye Quinn graduated with a first-class honours degree in Molecular Biology & Genetics from the University of Westminster and was awarded the Top Student Award by the Royal Society of Biology. She obtained a Master’s degree with distinction in Genetics of Human Disease from University College London. Skye joined the lab in 2018 and focusses on modification of IVT-mRNA for controlled gene expression.
Rafaela Konstantinidi graduated from Sheffield University with a BSc in Biomedical Science and in 2019 gained a Master's degree with distinction in Genes, Drugs and Stem Cells – Novel Therapies at Imperial College London. Rafaela is undertaking a PhD in the Patel lab investigating genetic manipulation of airways disease.
Emmanuel Okwelogu; graduated with a distinction in the Masters in Genes, Drugs and Stem cells - Novel therapies at Imperial College London 2019. Emmanuel's MSc project focused on development of biodegradable delivery systems for gene therapy in collaboration with the dept of Bioengineering.